{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:03:12Z","timestamp":1790301792999,"version":"4.1.0"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.wneu.2021.08.073","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T11:51:37Z","timestamp":1629719497000},"page":"e418-e438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["The Clinical Use of Serum Biomarkers in Traumatic Brain Injury: A Systematic Review Stratified by Injury Severity"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7803-8103","authenticated-orcid":false,"given":"Nadeem","family":"Al-Adli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5097-4773","authenticated-orcid":false,"given":"Omar S.","family":"Akbik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6293-8510","authenticated-orcid":false,"given":"Benjamin","family":"Rail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8255-2455","authenticated-orcid":false,"given":"Eric","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umaru","family":"Barrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaleen","family":"Vira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazin","family":"Al Tamimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Bagley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3499-7569","authenticated-orcid":false,"given":"Salah G.","family":"Aoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2021.08.073_bib3","first-page":"1","article-title":"Traumatic brain injury (TBI): overview of diagnosis and treatment","volume":"5","author":"Chung","year":"2013","journal-title":"J\u00a0Neurol Neurophysiol"},{"key":"10.1016\/j.wneu.2021.08.073_bib4","series-title":"Evaluation of the Disability Determination Process for Traumatic Brain Injury in Veterans","first-page":"23","year":"2019"},{"key":"10.1016\/j.wneu.2021.08.073_bib5","first-page":"2878","article-title":"Recent advances in traumatic brain injury","volume":"266","author":"Khellaf","year":"2019","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.wneu.2021.08.073_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4097\/kjae.2018.71.1.12","article-title":"Management of traumatic brain injury patients","volume":"71","author":"Dash","year":"2018","journal-title":"Korean J Anesthesiol"},{"key":"10.1016\/j.wneu.2021.08.073_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11910-016-0672-3","article-title":"The utility of cerebral blood flow assessment in TBI","volume":"16","author":"Akbik","year":"2016","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.wneu.2021.08.073_bib8","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1089\/neu.2009.0961","article-title":"Spreading depolarizations and late secondary insults after traumatic brain injury","volume":"26","author":"Hartings","year":"2009","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/diagnostics6040037","article-title":"Fluid biomarkers of traumatic brain injury and intended context of use","volume":"6","author":"Bogoslovsky","year":"2016","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.wneu.2021.08.073_bib10","author":"Puffer"},{"key":"10.1016\/j.wneu.2021.08.073_bib11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3389\/fneur.2020.00685","article-title":"Plasma biomarker for post-concussive syndrome: a pilot study using an alternating current electro-kinetic platform","volume":"11","author":"Lewis","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.wneu.2021.08.073_bib12","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1212\/WNL.0000000000009983","article-title":"Neurofilament light as a biomarker in traumatic brain injury","volume":"95","author":"Shahim","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2021.08.073_bib13","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.3390\/ijms21155381","article-title":"miR-142-3p expression is predictive for severe traumatic brain injury (TBI) in trauma patients","volume":"21","author":"Schindler","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.wneu.2021.08.073_bib14","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1089\/neu.2010.1564","article-title":"Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids","volume":"28","author":"Brophy","year":"2011","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib15","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1089\/neu.2012.2606","article-title":"S100B protein may detect brain death development after severe traumatic brain injury","volume":"30","author":"Egea-Guerrero","year":"2013","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib16","doi-asserted-by":"crossref","first-page":"e94370","DOI":"10.1371\/journal.pone.0094370","article-title":"Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury","volume":"9","author":"Lorente","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2021.08.073_bib17","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1136\/emj.2010.091363","article-title":"How does extracerebral trauma affect the clinical value of S100B measurements?","volume":"28","author":"Ohrt-Nissen","year":"2011","journal-title":"Emerg Med J"},{"key":"10.1016\/j.wneu.2021.08.073_bib18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cca.2012.09.025","article-title":"Role of S100B protein in urine and serum as an early predictor of mortality after severe traumatic brain injury in adults","volume":"414","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.wneu.2021.08.073_bib19","doi-asserted-by":"crossref","first-page":"e0129082","DOI":"10.1371\/journal.pone.0129082","article-title":"Serum total cholinesterase activity on admission is associated with disease severity and outcome in patients with traumatic brain Injury","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2021.08.073_bib20","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4103\/0028-3886.144439","article-title":"Diagnostic and prognostic significance of suPAR in traumatic brain injury","volume":"62","author":"Yu","year":"2014","journal-title":"Neurol India"},{"key":"10.1016\/j.wneu.2021.08.073_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fncir.2019.00026","article-title":"Lower posttraumatic \u03b1-synuclein level associated with altered default mode network connectivity following acute mild traumatic brain injury","volume":"13","author":"Ye","year":"2019","journal-title":"Front Neural Circuits"},{"key":"10.1016\/j.wneu.2021.08.073_bib22","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/jnc.13534","article-title":"Elevated serum miR-93, miR-191, and miR-499 are noninvasive biomarkers for the presence and progression of traumatic brain injury","volume":"137","author":"Yang","year":"2016","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.wneu.2021.08.073_bib23","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.clinbiochem.2015.05.015","article-title":"Serum neurogranin measurement as a biomarker of acute traumatic brain injury","volume":"48","author":"Yang","year":"2015","journal-title":"Clin Biochem"},{"key":"10.1016\/j.wneu.2021.08.073_bib24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/jnc.14717","article-title":"Screening the expression of several miRNAs from TaqMan Low Density Array in traumatic brain injury: miR-219a-5p regulates neuronal apoptosis by modulating CCNA2 and CACUL1","volume":"150","author":"Yan","year":"2019","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.wneu.2021.08.073_bib25","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1089\/neu.2012.2791","article-title":"The prognostic significance of the serum biomarker heart-fatty acidic binding protein in comparison with s100b in severe traumatic brain injury","volume":"30","author":"Walder","year":"2013","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib26","doi-asserted-by":"crossref","first-page":"e0173798","DOI":"10.1371\/journal.pone.0173798","article-title":"A\u00a0blood-based biomarker panel to risk-stratify mild traumatic brain injury","volume":"12","author":"Sharma","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2021.08.073_bib27","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1212\/WNL.0000000000003912","article-title":"Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports","volume":"88","author":"Shahim","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2021.08.073_bib28","doi-asserted-by":"crossref","first-page":"36791","DOI":"10.1038\/srep36791","article-title":"Serum neurofilament light protein predicts clinical outcome in traumatic brain injury","volume":"6","author":"Shahim","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.wneu.2021.08.073_bib29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000342141","article-title":"Interleukin-10 is an independent biomarker of severe traumatic brain injury prognosis","volume":"19","author":"Schneider Soares","year":"2012","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.wneu.2021.08.073_bib30","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1089\/neu.2013.3178","article-title":"Elevated cell-free plasma DNA level as an independent predictor of mortality in patients with severe traumatic brain injury","volume":"31","author":"Rodrigues Filho","year":"2014","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13054-017-1620-6","article-title":"Catecholamines as outcome markers in isolated traumatic brain injury: the COMA-TBI study","volume":"21","author":"Rizoli","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.wneu.2021.08.073_bib32","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1089\/neu.2010.1481","article-title":"Human traumatic brain injury alters plasma microRNA levels","volume":"27","author":"Redell","year":"2010","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib33","doi-asserted-by":"crossref","first-page":"e0204051","DOI":"10.1371\/journal.pone.0204051","article-title":"Expression profile of plasma microRNAs and their roles in diagnosis of mild to severe traumatic brain injury","volume":"13","author":"Qin","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2021.08.073_bib34","doi-asserted-by":"crossref","first-page":"e0117286","DOI":"10.1371\/journal.pone.0117286","article-title":"Plasma soluble prion protein, a potential biomarker for sport-related concussions: a pilot study","volume":"10","author":"Pham","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2021.08.073_bib35","first-page":"501","article-title":"Immune biomarkers for the diagnosis of mild traumatic brain injury","volume":"40","author":"Petrone","year":"2017","journal-title":"NeuroRehabilitation"},{"key":"10.1016\/j.wneu.2021.08.073_bib36","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12974-015-0444-z","article-title":"Low serum ficolin-3 levels are associated with severity and poor outcome in traumatic brain injury","volume":"12","author":"Pan","year":"2015","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.wneu.2021.08.073_bib37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/jcla.20201","article-title":"Diagnostic value of Elecsys S100 as a marker of acute brain injury in the emergency department","volume":"21","author":"Oh","year":"2007","journal-title":"J\u00a0Clin Lab Anal"},{"key":"10.1016\/j.wneu.2021.08.073_bib38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00701-007-1489-2","article-title":"Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury","volume":"150","author":"Nyl\u00e9n","year":"2008","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2021.08.073_bib39","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3109\/02699052.2012.700083","article-title":"Increased levels of serum MAP-2 at 6-months correlate with improved outcome in survivors of severe traumatic brain injury","volume":"26","author":"Mondello","year":"2012","journal-title":"Brain Inj"},{"key":"10.1016\/j.wneu.2021.08.073_bib40","doi-asserted-by":"crossref","first-page":"e1537","DOI":"10.1016\/j.wneu.2019.03.179","article-title":"Nonsurviving patients with severe traumatic brain injury have maintained high serum sCD40L levels","volume":"126","author":"Lorente","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.08.073_bib41","doi-asserted-by":"crossref","first-page":"e0121739","DOI":"10.1371\/journal.pone.0121739","article-title":"Serum levels of caspase-cleaved cytokeratin-18 in patients with severe traumatic brain injury are associated with mortality: a pilot study","volume":"10","author":"Lorente","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2021.08.073_bib42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13054-015-0911-z","article-title":"Serum substance P levels are associated with severity and mortality in patients with severe traumatic brain injury","volume":"19","author":"Lorente","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.wneu.2021.08.073_bib43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12883-015-0378-1","article-title":"Total antioxidant capacity is associated with mortality of patients with severe traumatic brain injury","volume":"15","author":"Lorente","year":"2015","journal-title":"BMC Neurol"},{"key":"10.1016\/j.wneu.2021.08.073_bib44","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1097\/CCM.0b013e3182186cee","article-title":"Endothelial progenitor cells correlate with clinical outcome of traumatic brain injury","volume":"39","author":"Liu","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.wneu.2021.08.073_bib45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.clineuro.2016.02.032","article-title":"The role of vascular endothelial growth factor and vascular endothelial growth inhibitor in clinical outcome of traumatic brain injury","volume":"144","author":"Li","year":"2016","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.wneu.2021.08.073_bib46","doi-asserted-by":"crossref","first-page":"e0175572","DOI":"10.1371\/journal.pone.0175572","article-title":"H-FABP: a new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury","volume":"12","author":"Lagerstedt","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2021.08.073_bib47","doi-asserted-by":"crossref","first-page":"e84977","DOI":"10.1371\/journal.pone.0084977","article-title":"Subject-specific increases in serum S-100B distinguish sports-related concussion from sports-related exertion","volume":"9","author":"Kiechle","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2021.08.073_bib48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.clineuro.2016.04.005","article-title":"Early CSF and serum S100B concentrations for outcome prediction in traumatic brain injury and subarachnoid hemorrhage","volume":"145","author":"Kellermann","year":"2016","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.wneu.2021.08.073_bib49","doi-asserted-by":"crossref","first-page":"183821","DOI":"10.1155\/2015\/183821","article-title":"Determination of serum lost goodwill target proteome in patients with severe traumatic brain injury","volume":"2015","author":"Ji","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.wneu.2021.08.073_bib50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1742-2094-7-19","article-title":"Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury","volume":"7","author":"Hergenroeder","year":"2010","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.wneu.2021.08.073_bib51","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1089\/neu.2012.2579","article-title":"S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury","volume":"30","author":"Goyal","year":"2013","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib52","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1620\/tjem.211.387","article-title":"Plasma interleukin-8 as a potential predictor of mortality in adult patients with severe traumatic brain injury","volume":"211","author":"Gopcevic","year":"2007","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.wneu.2021.08.073_bib53","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cca.2018.01.044","article-title":"Serum S100A12 as a prognostic biomarker of severe traumatic brain injury","volume":"480","author":"Feng","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.wneu.2021.08.073_bib54","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1016\/j.transproceed.2013.10.021","article-title":"Serologic behavior of S100B protein in patients who are brain dead: preliminary results","volume":"45","author":"Egea-Guerrero","year":"2013","journal-title":"Transpl Proc"},{"key":"10.1016\/j.wneu.2021.08.073_bib55","doi-asserted-by":"crossref","first-page":"R190","DOI":"10.1186\/cc9307","article-title":"Resistin is associated with mortality in patients with traumatic brain injury","volume":"14","author":"Dong","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.wneu.2021.08.073_bib56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1757-7241-20-83","article-title":"Matrix metalloproteinase 9 and cellular fibronectin plasma concentrations are predictors of the composite endpoint of length of stay and death in the intensive care unit after severe traumatic brain injury","volume":"20","author":"Copin","year":"2012","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"10.1016\/j.wneu.2021.08.073_bib57","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1089\/neu.2008.0738","article-title":"Validation of serum markers for blood-brain barrier disruption in traumatic brain injury","volume":"26","author":"Blyth","year":"2009","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib58","doi-asserted-by":"crossref","first-page":"28148","DOI":"10.1038\/srep28148","article-title":"A\u00a0panel of serum MiRNA biomarkers for the diagnosis of severe to mild traumatic brain injury in humans","volume":"6","author":"Bhomia","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.wneu.2021.08.073_bib59","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13104-017-2459-2","article-title":"RANTES levels in peripheral blood, CSF and contused brain tissue as a marker for outcome in traumatic brain injury (TBI) patients","volume":"10","author":"Albert","year":"2017","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.wneu.2021.08.073_bib60","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s13054-016-1470-7","article-title":"Plasma cytokines IL-6, IL-8, and IL-10 are associated with the development of acute respiratory distress syndrome in patients with severe traumatic brain injury","volume":"20","author":"Aisiku","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.wneu.2021.08.073_bib61","doi-asserted-by":"crossref","first-page":"263","DOI":"10.33549\/physiolres.931253","article-title":"Correlation of ultrastructural changes of endothelial cells and astrocytes occurring during blood brain barrier damage after traumatic brain injury with biochemical markers of BBB leakage and inflammatory response","volume":"58","author":"Vajtr","year":"2009","journal-title":"Physiol Res"},{"key":"10.1016\/j.wneu.2021.08.073_bib62","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10143-008-0148-2","article-title":"Serum neuron-specific enolase as a predictor of short-term outcome and its correlation with Glasgow Coma Scale in traumatic brain injury","volume":"31","author":"Guzel","year":"2008","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.wneu.2021.08.073_bib63","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1089\/neu.2008.0868","article-title":"Resuscitation with hypertonic saline-dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients","volume":"26","author":"Baker","year":"2009","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib64","first-page":"778","article-title":"Glial fibrillary acidic protein is highly correlated with brain injury","volume":"65","author":"Lumpkins","year":"2008","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib65","doi-asserted-by":"crossref","first-page":"R156","DOI":"10.1186\/cc10286","article-title":"Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study","volume":"15","author":"Mondello","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.wneu.2021.08.073_bib66","doi-asserted-by":"crossref","first-page":"e0193278","DOI":"10.1371\/journal.pone.0193278","article-title":"Early measurement of interleukin-10 predicts the absence of CT scan lesions in mild traumatic brain injury","volume":"13","author":"Lagerstedt","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2021.08.073_bib67","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1212\/WNL.0b013e3181fd62d2","article-title":"GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study","volume":"75","author":"Vos","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2021.08.073_bib68","doi-asserted-by":"crossref","first-page":"e96296","DOI":"10.1371\/journal.pone.0096296","article-title":"Significance of ubiquitin carboxy-terminal hydrolase L1 elevations in athletes after sub-concussive head hits","volume":"9","author":"Puvenna","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2021.08.073_bib69","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1227\/NEU.0000000000001226","article-title":"The levels of glial fibrillary acidic protein and ubiquitin c-terminal hydrolase-l1 during the first week after a traumatic brain injury: correlations with clinical and imaging findings","volume":"79","author":"Posti","year":"2016","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2021.08.073_bib70","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.wneu.2015.10.066","article-title":"Glial fibrillary acidic protein and ubiquitin c-terminal hydrolase-l1 as outcome predictors in traumatic brain injury","volume":"87","author":"Takala","year":"2016","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.08.073_bib71","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jocn.2016.09.006","article-title":"Elevation of oxidative stress indicators in a pilot study of plasma following traumatic brain injury","volume":"35","author":"Halstrom","year":"2017","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2021.08.073_bib72","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12974-016-0500-3","article-title":"Inflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injury","volume":"13","author":"Di Battista","year":"2016","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.wneu.2021.08.073_bib73","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/02699052.2018.1432892","article-title":"An investigation of neuroinjury biomarkers after sport-related concussion: from the subacute phase to clinical recovery","volume":"32","author":"Di Battista","year":"2018","journal-title":"Brain Inj"},{"key":"10.1016\/j.wneu.2021.08.073_bib74","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/jcph.980","article-title":"Effect of memantine on serum levels of neuron-specific enolase and on the glasgow coma scale in patients with moderate traumatic brain injury","volume":"58","author":"Mokhtari","year":"2018","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.wneu.2021.08.073_bib75","doi-asserted-by":"crossref","first-page":"e2133","DOI":"10.1212\/WNL.0000000000006617","article-title":"Concussion BASICS III: serum biomarker changes following sport-related concussion","volume":"91","author":"Asken","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2021.08.073_bib76","doi-asserted-by":"crossref","first-page":"e0200394","DOI":"10.1371\/journal.pone.0200394","article-title":"Combining H-FABP and GFAP increases the capacity to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury","volume":"13","author":"Lagerstedt","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2021.08.073_bib77","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/acem.13174","article-title":"Utility of serum biomarkers in the diagnosis and stratification of mild traumatic brain injury","volume":"24","author":"Lewis","year":"2017","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.wneu.2021.08.073_bib78","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S1474-4422(18)30231-X","article-title":"Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study","volume":"17","author":"Bazarian","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.wneu.2021.08.073_bib79","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/neu.2015.3949","article-title":"Circulating brain-derived neurotrophic factor has diagnostic and prognostic value in traumatic brain injury","volume":"33","author":"Korley","year":"2016","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib80","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1089\/neu.2011.2127","article-title":"Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator","volume":"29","author":"Czeiter","year":"2012","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib81","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00701-012-1292-6","article-title":"The release of S-100B and NSE in severe traumatic head injury is associated with APOE \u03b54","volume":"154","author":"Olivecrona","year":"2012","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2021.08.073_bib82","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/neu.2015.4149","article-title":"Ability of serum glial fibrillary acidic protein, ubiquitin C-terminal hydrolase-L1, and S100B to differentiate normal and abnormal head computed tomography findings in patients with suspected mild or moderate traumatic brain injury","volume":"33","author":"Welch","year":"2016","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib83","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3233\/JAD-2012-120598","article-title":"Elevated plasma MCP-1 concentration following traumatic brain injury as a potential \u201cpredisposition\u201d factor associated with an increased risk for subsequent development of Alzheimer\u2019s disease","volume":"31","author":"Ho","year":"2012","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.wneu.2021.08.073_bib84","first-page":"104","article-title":"Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase","volume":"69","author":"Honda","year":"2010","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib85","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/TA.0b013e3182491e3d","article-title":"Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention","volume":"72","author":"Papa","year":"2012","journal-title":"J\u00a0Trauma Acute Care Surg"},{"key":"10.1016\/j.wneu.2021.08.073_bib86","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1212\/WNL.0000000000007864","article-title":"Acute elevation of serum inflammatory markers predicts symptom recovery after concussion","volume":"93","author":"Nitta","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2021.08.073_bib87","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1089\/neu.2011.2092","article-title":"Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury","volume":"29","author":"Mondello","year":"2012","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib88","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jss.2008.12.022","article-title":"Tau proteins in serum predict outcome after severe traumatic brain injury","volume":"160","author":"Liliang","year":"2010","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.wneu.2021.08.073_bib89","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1212\/WNL.0000000000003587","article-title":"Acute plasma tau relates to prolonged return to play after concussion","volume":"88","author":"Gill","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2021.08.073_bib90","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1089\/neu.2013.3245","article-title":"GFAP out-performs S100\u03b2 in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions","volume":"31","author":"Papa","year":"2014","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib91","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/01616412.2016.1144410","article-title":"S100B and neuron-specific enolase as mortality predictors in patients with severe traumatic brain injury","volume":"38","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2016","journal-title":"Neurol Res"},{"key":"10.1016\/j.wneu.2021.08.073_bib92","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s13054-015-1081-8","article-title":"Glial fibrillary acidic protein as a biomarker in severe traumatic brain injury patients: a prospective cohort study","volume":"19","author":"Lei","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.wneu.2021.08.073_bib93","first-page":"666","article-title":"Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury","volume":"70","author":"Mondello","year":"2012","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2021.08.073_bib94","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/1545968315600525","article-title":"Preliminary associations between brain-derived neurotrophic factor, memory impairment, functional cognition, and depressive symptoms following severe TBI","volume":"30","author":"Failla","year":"2016","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1016\/j.wneu.2021.08.073_bib95","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1089\/neu.2014.3698","article-title":"Serum SNTF increases in concussed professional ice hockey players and relates to the severity of postconcussion symptoms","volume":"32","author":"Siman","year":"2015","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib96","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1089\/neu.2013.2883","article-title":"GFAP-BDP as an acute diagnostic marker in traumatic brain injury: results from the prospective transforming research and clinical knowledge in traumatic brain injury study","volume":"30","author":"Okonkwo","year":"2013","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib97","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cjtee.2018.12.004","article-title":"Use of neuron-specific enolase to predict mild brain injury in motorcycle crash patients with maxillofacial fractures: a pilot study","volume":"22","author":"Ruslin","year":"2019","journal-title":"Chin J Traumatol"},{"key":"10.1016\/j.wneu.2021.08.073_bib98","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1089\/neu.2014.3635","article-title":"Measurement of the glial fibrillary acidic protein and its breakdown products GFAP-BDP biomarker for the detection of traumatic brain injury compared to computed tomography and magnetic resonance imaging","volume":"32","author":"McMahon","year":"2015","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib99","doi-asserted-by":"crossref","first-page":"e0159929","DOI":"10.1371\/journal.pone.0159929","article-title":"Altered blood biomarker profiles in athletes with a history of repetitive head impacts","volume":"11","author":"Di Battista","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2021.08.073_bib100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12974-019-1402-y","article-title":"Evidence of a distinct peripheral inflammatory profile in sport-related concussion","volume":"16","author":"Di Battista","year":"2019","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.wneu.2021.08.073_bib101","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/02688697.2017.1297378","article-title":"A\u00a0prospective pilot study on serum cleaved tau protein as a neurological marker in severe traumatic brain injury","volume":"31","author":"Pandey","year":"2017","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.wneu.2021.08.073_bib102","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1089\/neu.2015.3881","article-title":"Plasma anti-glial fibrillary acidic protein autoantibody levels during the acute and chronic phases of traumatic brain injury: a transforming research and clinical knowledge in traumatic brain injury pilot study","volume":"33","author":"Wang","year":"2016","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib103","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13054-016-1450-y","article-title":"Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity","volume":"20","author":"Thelin","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.wneu.2021.08.073_bib104","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1001\/jamaneurol.2014.367","article-title":"Blood biomarkers for brain injury in concussed professional ice hockey players","volume":"71","author":"Shahim","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.wneu.2021.08.073_bib105","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.4103\/njcp.njcp_431_17","article-title":"Diagnostic value of serum glial fibrillary acidic protein and S100B serum levels in emergency medicine patients with traumatic versus nontraumatic intracerebral hemorrhage","volume":"21","author":"Aydin","year":"2018","journal-title":"Niger J Clin Pract"},{"key":"10.1016\/j.wneu.2021.08.073_bib106","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1089\/neu.2013.3087","article-title":"Post-traumatic hypoxia is associated with prolonged cerebral cytokine production, higher serum biomarker levels, and poor outcome in patients with severe traumatic brain injury","volume":"31","author":"Yan","year":"2014","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib107","doi-asserted-by":"crossref","first-page":"e80296","DOI":"10.1371\/journal.pone.0080296","article-title":"Combining biochemical and imaging markers to improve diagnosis and characterization of mild traumatic brain injury in the acute setting: results from a pilot study","volume":"8","author":"Kou","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2021.08.073_bib108","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1089\/neu.2016.4772","article-title":"Modeling the kinetics of serum glial fibrillary acidic protein, ubiquitin carboxyl-terminal hydrolase-L1, and S100B concentrations in patients with traumatic brain injury","volume":"34","author":"Welch","year":"2017","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib109","doi-asserted-by":"crossref","first-page":"e0214381","DOI":"10.1371\/journal.pone.0214381","article-title":"Tau protein as a diagnostic marker for diffuse axonal injury","volume":"14","author":"Tomita","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2021.08.073_bib110","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/jamaneurol.2016.0039","article-title":"Time course and diagnostic accuracy of glial and neuronal blood biomarkers GFAP and UCH-L1 in a large cohort of trauma patients with and without mild traumatic brain injury","volume":"73","author":"Papa","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.wneu.2021.08.073_bib111","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.1016\/j.wneu.2019.04.170","article-title":"Glial fibrillary acidic protein (GFAP) outperforms S100 calcium-binding protein B (S100B) and ubiquitin c-terminal hydrolase l1 (UCH-l1) as predictor for positive computed tomography of the head in trauma subjects","volume":"128","author":"Mahan","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.08.073_bib112","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/neu.2013.3040","article-title":"Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein","volume":"31","author":"Diaz-Arrastia","year":"2014","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib113","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2018.09.035","article-title":"Serum ST2 as a potential prognostic biomarker for traumatic brain injury","volume":"487","author":"Du","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.wneu.2021.08.073_bib114","first-page":"631","article-title":"Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial","volume":"125","author":"Raheja","year":"2016","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2021.08.073_bib115","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.12688\/f1000research.20445.1","article-title":"Discovery of novel plasma biomarker ratios to discriminate traumatic brain injury","volume":"8","author":"Chen","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.wneu.2021.08.073_bib116","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1089\/neu.2017.5046","article-title":"Prospective assessment of acute blood markers of brain injury in sport-related concussion","volume":"34","author":"Meier","year":"2017","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib117","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cca.2019.07.008","article-title":"Usefulness of serum interleukin-33 as a prognostic marker of severe traumatic brain injury","volume":"497","author":"Zhang","year":"2019","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.wneu.2021.08.073_bib118","doi-asserted-by":"crossref","first-page":"e1780","DOI":"10.1212\/WNL.0000000000005518","article-title":"Neurofilament light and tau as blood biomarkers for sports-related concussion","volume":"90","author":"Shahim","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2021.08.073_bib119","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/neu.2015.4333","article-title":"Increases of plasma levels of glial fibrillary acidic protein, tau, and amyloid \u03b2 up to 90 days after traumatic brain injury","volume":"34","author":"Bogoslovsky","year":"2017","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2021.08.073_bib120","doi-asserted-by":"crossref","first-page":"e1385","DOI":"10.1212\/WNL.0000000000006321","article-title":"Glial fibrillary acidic protein elevations relate to neuroimaging abnormalities after mild TBI","volume":"91","author":"Gill","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2021.08.073_bib121","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1096\/fj.201802319R","article-title":"Altered levels of plasma neuron-derived exosomes and their cargo proteins characterize acute and chronic mild traumatic brain injury","volume":"33","author":"Goetzl","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.wneu.2021.08.073_bib122","doi-asserted-by":"crossref","first-page":"e0210128","DOI":"10.1371\/journal.pone.0210128","article-title":"Inflammasome proteins as biomarkers of traumatic brain injury","volume":"13","author":"Kerr","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2021.08.073_bib123","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jamaneurol.2017.0655","article-title":"Comparing plasma phospho tau, total tau, and phospho tau-total tau ratio as acute and chronic traumatic brain injury biomarkers","volume":"74","author":"Rubenstein","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.wneu.2021.08.073_bib124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2018.03.002","article-title":"Blood biomarkers are associated with brain function and blood flow following sport concussion","volume":"319","author":"Di Battista","year":"2018","journal-title":"J\u00a0Neuroimmunol"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875021012432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875021012432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:58:56Z","timestamp":1761814736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875021012432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":122,"alternative-id":["S1878875021012432"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2021.08.073","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Clinical Use of Serum Biomarkers in Traumatic Brain Injury: A Systematic Review Stratified by Injury Severity","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2021.08.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}